Abstract 930: CB213: A half-life extended bispecific Humabody VH delivering dual checkpoint blockade to reverse the dysfunction of LAG3+PD-1+ double-positive T cells

Authors: James William Legg, Brian McGuinness, Hugo Arasanz, Ana Bocanegra, Phillip Bartlett, Giovanni Benedetti, Neil Birkett, Carl Cox, Elena De Juan, Carrie Enever, Emma Hames, Grazyna Kochan, Maria Jesus Garcia-Granda, Angelica Sette, Yumin Teng, Lorraine Thompson, Ruth Vera, Richard Williams, Miren Zuazo, David Escors, Carolyn Edwards

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-930

Source: Full article